Surface Oncology, Inc. (SURF) Social Stream
SURFACE ONCOLOGY INC (SURF) Price Targets From Analysts
Use the tables below to see what analysts covering SURFACE ONCOLOGY INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 4 | $17 | $14 | $15 | $1.07 | 1301.87% |
| 2022-03-03 | 5 | $17 | $10 | $13.75 | $1.07 | 1185.05% |
| 2022-05-10 | 4 | $17 | $10 | $13.666 | $1.07 | 1177.2% |
| 2022-05-11 | 4 | $17 | $10 | $13 | $1.07 | 1114.95% |
| 2022-08-04 | 3 | $12 | $10 | $11 | $1.07 | 928.04% |
| 2022-08-08 | 3 | $12 | $8.5 | $10.25 | $1.07 | 857.94% |
| 2023-03-10 | 2 | $6 | $3 | $5.25 | $1.07 | 390.65% |
| 2023-05-05 | 3 | $6 | $3 | $5.25 | $1.07 | 390.65% |
| 2023-08-02 | 4 | $6 | $1.15 | $4.537 | $1.07 | 324.02% |
The Trend in the Analyst Price Target
Over the past 24 months, SURF's average price target has gone down $11.06.
SURF reports an average of 552.1% for its upside potential over the past 39 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-03 | 3 | 6 | 3.00 | 5.250 | 1.230 | 326.83% |
| 2022-11-03 | 2 | 6 | 3.00 | 5.250 | 1.230 | 326.83% |
| 2023-05-05 | 3 | 6 | 3.00 | 5.250 | 0.596 | 780.87% |
| 2023-05-05 | 4 | 6 | 3.00 | 5.250 | 0.596 | 780.87% |
| 2023-08-02 | 4 | 6 | 1.15 | 4.537 | 0.889 | 410.35% |
SURF Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.5 | 1 | 0 | 3 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
Over the past 15 months, SURF's average broker recommendation rating worsened by 1.5.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, SURFACE ONCOLOGY INC's upside potential (average analyst target price relative to current price) is greater than 1240.89% of them.
- To contextualize these metrics, consider that out of all US stocks, SURFACE ONCOLOGY INC's average analyst price target is greater than 153.15% of them.
- To contextualize these metrics, consider that out of all US stocks, SURFACE ONCOLOGY INC's number of analysts covering the stock is higher than 178.24% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, SURFACE ONCOLOGY INC's variance in analysts' estimates is lower than -293.2% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to SURFACE ONCOLOGY INC are SLDB, XFOR, and APTO.
View All Top Stocks by Price Target
Is SURF a Buy, Hold or Sell? See the POWR Ratings now!